# US 2015/0148368 A1 · Crystalline, anhydrous forms of oxymorphone hydrochloride

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0148368 A1
- Document ID: US20150148368A1
- Status: Published application
- Kind: A1
- Application number: 14/613,421
- Filed: 2015-02-04
- Published: 2015-05-28
- Earliest claimed: 2011-05-27
- Assignees: GrüNenthal GmbH
- Applicants: GrüNenthal GmbH
- Inventors: Andreas FISCHER; Dagmar Peters-Groth; Dagmar Lischke
- Web page: https://patentgrep.com/patent/US20150148368A1

## CPC

- C07D 489/08: Oxygen atom
- C07B 2200/13: Crystalline forms, e.g. polymorphs
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- C07B: GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR (preparation of carboxylic acid esters by telomerisation C07C67/47; telomerisation C08F)

## Abstract

Crystalline, anhydrous hydrochloride salts of 4,5α-epoxy-3,14-dihydroxy-17-methylmorphinan-6-one (oxymorphone) are disclosed and three polymorphic forms of these salts are reported. The invention further relates to a method for the production of such salts, a pharmaceutical composition comprising an effective amount of such a salt and such a salt as a medicament and for the treatment and/or prevention of pain.

## Claims

### Claim 1

A crystalline, anhydrous hydrochloride salt of 4,5α-epoxy-3,14-dihydroxy-17-methylmorphinan-6-one according to formula (I):

### Claim 2 (depends on 1)

The hydrochloride salt according to claim 1, wherein the melting or sublimation temperature, defined as the peak temperature in a differential scanning calorimetry measurement at a heating rate of 10° C./minute, is 250° C.

### Claim 3 (depends on 1)

The hydrochloride salt according to claim 1, wherein the X-ray powder diffractogram of the salt comprises one or more of the following reflexes (±0.2 in 2θ): 12.7, 14.7, 16.2, 17.1, 19.0.

### Claim 4 (depends on 1)

The hydrochloride salt according to claim 1, wherein the X-ray powder diffractogram of the salt comprises one or more of the following reflexes (±0.2 in 2θ): 6.0, 13.1, 13.6, 15.3, 16.5, 22.4, 22.6, 24.1.

### Claim 5 (depends on 1)

The hydrochloride salt according to claim 1, wherein the X-ray powder diffractogram of the salt comprises one or more of the following reflexes (±0.2 in 2θ): 8.3, 16.1, 18.6, 20.9, 28.0, 29.9.

### Claim 6 (depends on 1)

A method for the production of a crystalline, anhydrous hydrochloride salt of 4,5α-epoxy-3,14-dihydroxy-17-methylmorphinan-6-one of formula (I) according to claim 1, comprising the steps of:
providing a hydrate hydrochloride salt of 4,5α-epoxy-3,14-dihydroxy-17-methylmorphinan-6-on of formula (I); and
heating to a temperature of ≧130° C. to ≦210° C.

### Claim 7 (depends on 6)

The method according to claim 6, further comprising the step of grinding the hydrate hydrochloride salt of 4,5α-epoxy-3,14-dihydroxy-17-methylmorphinan-6-one of formula (I) prior to heating.

### Claim 8 (depends on 6)

The method according to claim 6, wherein the heating is conducted during a hot-melt extrusion process.

### Claim 9 (depends on 1)

A pharmaceutical composition comprising an effective amount of a crystalline, anhydrous hydrochloride salt of 4,5α-epoxy-3,14-dihydroxy-17-methylmorphinan-6-one of formula (I) according to claim 1.

### Claim 10 (depends on 1)

A method of treating and/or preventing pain in a patient in need of such treatment, said method comprising administering to said patient an effective amount therefor of a crystalline, anhydrous hydrochloride salt of 4,5α-epoxy-3,14-dihydroxy-17-methylmorphinan-6-one of formula (I) according to claim 1.
